In a 2½‑year‑old child with global developmental delay, severe separation anxiety, ARFID, recent improvements in language, sleep, and constipation but worsening physical aggression, new bilateral eye‑blinking motor tics, and heightened tactile sensitivities, what differential diagnoses and medical contributors should be considered, which previously suspected factors become less likely, what assessments (medical, neurologic, sensory, behavioral) are indicated before initiating risperidone, and what documentation should be presented at the multidisciplinary case conference?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Critical Analysis for Multidisciplinary Case Conference: Worsening Aggression in a 2½-Year-Old with Global Developmental Delay

What Your Team Should Prioritize: Medical Pain Sources First

Before attributing aggression to behavioral or neurodevelopmental factors, your physicians must systematically exclude occult medical pain sources that young children with limited language cannot localize. 1 This is particularly critical because your child's improvements in communication, sleep, and constipation make previously suspected triggers less likely—yet aggression has paradoxically worsened.

Medical Contributors Your Team Must Rule Out

Pain-related medical conditions are frequently overlooked in children with intellectual/developmental disabilities and manifest as behavioral symptoms, including aggression. 1 Your developmental pediatrician should specifically assess:

Gastrointestinal Sources (Beyond Constipation)

  • Gastroesophageal reflux disease (GERD): The sudden screaming and tongue-scraping during eating—even with familiar safe foods like pho—could indicate reflux-related esophageal pain or oral hypersensitivity from acid exposure 2
  • Oral/dental pain: Dental problems (caries, erupting molars) are common in children with developmental delays and can cause aggression 1
  • Residual GI dysmotility: Even without retained stool, visceral hypersensitivity or intermittent cramping may persist

Neurological Assessment Required

The new bilateral eye-blinking tics fundamentally change your differential and warrant neurological evaluation. 2 Your team should consider:

  • EEG to exclude seizure activity: Motor tics can occasionally represent subtle seizure phenomena; the unprovoked aggression (hitting while calmly breastfeeding) raises concern for possible ictal or post-ictal irritability 2
  • Brain MRI if not previously obtained: Guidelines recommend neuroimaging for children with global developmental delay when there are changes in neurologic examination or new motor findings 2, 3
  • Tic disorder evaluation: The temporal relationship between tic emergence and worsening aggression may indicate shared pathophysiology (CSTC circuit dysfunction) 4

Other Pain Sources

  • Ear infections/hearing issues: Can present as aggression in nonverbal children 1
  • Headaches/migraines: Difficult to communicate at this age
  • Musculoskeletal pain: From positioning, tone abnormalities, or injury

What Becomes LESS Likely Given Clinical Improvements

Your reasoning is sound that several previously suspected contributors are now less probable:

  • Constipation/GI pain: GI confirms no retained stool; child is happier overall
  • Pure communication frustration: Language has "exploded" and he can now communicate what bothers him
  • Sleep deprivation: Now sleeping through the night
  • Generalized dysregulation: Substantially more redirectable, less reliant on breastfeeding for regulation

However, this paradox—improvements in multiple domains with worsening aggression—strongly suggests either (1) an unidentified medical pain source, (2) a progressive neurological process, or (3) a neurodevelopmental condition with emerging behavioral phenotype.

Sensory Profile: Critical Reassessment Needed

The tactile defensiveness, clothing aversion, hand-fisting to avoid contamination, and food-scraping behaviors represent significant sensory processing differences that meaningfully alter the clinical picture. 2

What This Sensory Pattern Suggests

These observations indicate:

  • Severe tactile hypersensitivity: Not just preference but functional impairment (won't handle desired pizza, needs parent feeding)
  • Oral sensory defensiveness: The sudden screaming/scraping during eating may represent tactile hypersensitivity in the oral cavity rather than pain
  • Possible sensory-driven aggression: Hitting may occur when overwhelmed by sensory input that others cannot perceive

Your occupational therapist should conduct a comprehensive sensory processing evaluation using standardized tools. 2 This assessment should specifically examine whether aggression correlates with sensory triggers (tags, textures, environmental stimuli).

Alternative Explanation for Food Episodes

The sudden screaming/scraping-food-off-tongue could indicate:

  1. Oral tactile hypersensitivity (texture suddenly becomes intolerable)
  2. Temperature sensitivity (even if not "excessive" to you)
  3. Oral motor apraxia (difficulty coordinating swallow, leading to panic)
  4. GERD-related esophageal pain (delayed sensation after swallowing)

Speech-language pathology should perform videofluoroscopic swallow study if not already done to assess oral-motor coordination and rule out silent aspiration or swallowing dysfunction. 2, 5

Neurodevelopmental Reassessment: Autism Spectrum Without Assumption

Your child's clinical presentation—severe separation anxiety, ARFID, sensory sensitivities, motor tics, and aggression in the context of global developmental delay—warrants formal autism evaluation, but this should be approached as differential diagnosis, not presumptive diagnosis. 6, 7, 1

Why Reassessment Is Indicated Now

Several factors have changed since initial evaluation:

  • Language emergence allows better assessment of social communication, pragmatic language, and restricted interests
  • New motor tics may indicate broader neurodevelopmental involvement 4
  • Sensory profile is now clearer with his ability to communicate preferences
  • Behavioral phenotype is evolving as he matures

Specific Assessment Questions

Your developmental pediatrician should systematically evaluate:

Social Communication:

  • Does he use language primarily for requesting vs. social sharing?
  • Does he show joint attention, social referencing, reciprocal play?
  • Are there qualitative differences in social interaction beyond what developmental age would predict?

Restricted/Repetitive Behaviors:

  • Are the sensory sensitivities part of broader rigidity?
  • Are there repetitive motor mannerisms beyond tics?
  • Does he show intense, narrow interests?

Functional Behavior Assessment:

  • A formal functional behavioral assessment (FBA) by a psychologist or behavior analyst trained in applied behavior analysis is essential before medication. 2, 1
  • This should identify antecedents, consequences, and functions of aggression (escape, attention-seeking, sensory, pain-related)
  • Document whether aggression serves different functions in different contexts

When Risperidone Becomes Appropriate: Evidence-Based Thresholds

Risperidone should be reserved for aggression that: (1) poses safety risk, (2) persists despite addressing medical contributors and implementing behavioral interventions, and (3) significantly impairs functioning or access to therapies. 8

Required Assessments BEFORE Risperidone

Your conservative approach is evidence-aligned. Before antipsychotic medication at age 2½, your team should complete:

  1. Medical workup (above) to exclude pain sources
  2. Neurological evaluation including EEG given new tics 2
  3. Formal autism evaluation using ADOS-2 (calibrated for developmental level) 9
  4. Functional behavioral assessment with behavior intervention plan implementation 2, 1
  5. Occupational therapy sensory evaluation with sensory diet implementation 2
  6. Speech-language pathology assessment of communication adequacy and swallowing 2, 5
  7. Trial of behavioral interventions for minimum 8-12 weeks with data collection

Risperidone: Benefits and Risks at This Age

FDA approval exists for risperidone in children ≥5 years for irritability associated with autism, but your child is 2½ years old—this is off-label use with limited safety data in this age group. 8

Benefits (if indicated):

  • Reduction in aggression and irritability in autism-related behaviors
  • May allow access to therapies if aggression is barrier

Risks in young children: 8

  • Metabolic effects: Weight gain, hyperglycemia, dyslipidemia (monitor baseline and ongoing metabolic parameters)
  • Extrapyramidal symptoms: Dystonia, akathisia, parkinsonism
  • Sedation: May impair learning and development
  • Prolactin elevation: Gynecomastia, galactorrhea
  • Tardive dyskinesia risk: Potentially irreversible movement disorder (higher risk with longer duration)
  • Limited long-term safety data in children under 5 years

If risperidone is eventually indicated, dosing should start at 0.25 mg daily with slow titration (0.25 mg increments every 5-7 days) to minimize adverse effects. 8 Baseline and monitoring labs include: metabolic panel, lipid panel, hemoglobin A1c, prolactin level, weight/BMI, blood pressure, and movement disorder assessment (AIMS scale).

Critical Documentation for Case Conference

Bring structured data, not anecdotes, to enable evidence-based decision-making:

Video Documentation

  • Aggression episodes: Capture 5-10 examples showing antecedents, behavior, and consequences
  • Tic behaviors: Document frequency, duration, and contexts
  • Food refusal/scraping episodes: Show the sudden screaming/tongue-scraping
  • Sensory responses: Reactions to tags, dirty hands, textures
  • Positive interactions: Show his capabilities and regulation when successful

Quantitative Data (Collect for 2-4 Weeks)

  • Aggression frequency chart: Daily count of hits, by target person, time of day, and identified trigger (or "no identifiable trigger")
  • Severity rating: 1-5 scale for intensity of each episode
  • Duration: How long episodes last
  • Tic frequency: Daily count of eye-blinking episodes
  • Sleep log: Confirm sustained improvement
  • Food intake log: Document accepted foods, refusals, and scraping episodes

Contextual Patterns

  • Does aggression cluster around:
    • Transitions?
    • Sensory-rich environments?
    • Specific people or settings?
    • Times of day?
    • Before/after meals (suggesting hunger or GI discomfort)?

Standardized Measures

Request completion of:

  • Aberrant Behavior Checklist (ABC): Validated for developmental disabilities 1
  • Developmental Behavior Checklist (DBC): Assesses behavioral/emotional problems in intellectual disability 1
  • Sensory Profile 2: Quantifies sensory processing patterns

What You May Be Overlooking

Medication Side Effects

Review ALL current medications (including supplements, over-the-counter) for psychiatric/behavioral side effects. 1 Even seemingly benign medications (antihistamines, reflux medications, vitamins) can cause behavioral changes in young children.

Environmental Stressors

  • Has anything changed in the home environment (new sibling activities, parental stress, schedule changes)?
  • Are there inconsistencies in behavioral management across caregivers?

Developmental Regression

The combination of new tics and worsening behavior raises concern for possible regression or progressive neurological process. 2, 3 Your team should specifically ask:

  • Has he lost any previously acquired skills?
  • Are developmental gains plateauing?
  • Is head circumference tracking appropriately?

Genetic/Metabolic Evaluation

If not previously done, consider genetics referral for chromosomal microarray and possibly whole exome sequencing, given global developmental delay with evolving phenotype. 10, 11 Some genetic syndromes have behavioral phenotypes that emerge with age.

Weak Points in Current Reasoning

  1. Assuming constipation resolution eliminates GI contribution: Visceral hypersensitivity and GERD can persist independently
  2. Attributing all food behaviors to sensory issues: May miss oral-motor dysfunction or reflux
  3. Viewing tics as separate phenomenon: May share neurobiological substrate with aggression 4
  4. Underestimating impact of severe separation anxiety: This alone can drive aggression when separation is threatened or anticipated 12

Specific Questions Your Physicians Must Answer

  1. Has neuroimaging been performed? If not, is it indicated given new tics and global developmental delay? 2, 3
  2. What is the result of EEG? To exclude seizure contribution to unprovoked aggression 2
  3. Has formal autism evaluation been completed with ADOS-2? Calibrated for his developmental level 9
  4. What does functional behavioral assessment reveal about aggression function?
  5. Has swallow study been performed to assess oral-motor coordination?
  6. What is the result of comprehensive sensory evaluation by occupational therapy?
  7. Have you excluded all medical pain sources systematically?
  8. What behavioral interventions have been implemented with adequate duration and fidelity?
  9. Is there evidence of developmental regression or plateau?
  10. What is the safety risk of current aggression level—is immediate intervention required, or is there time for systematic evaluation?

Your instinct to understand the "why" before using an antipsychotic in a 2½-year-old is clinically sound and evidence-aligned. 1, 13 The paradox of worsening aggression despite multiple improvements demands systematic medical evaluation before attributing behavior to neurodevelopmental factors alone.

References

Research

Optimizing Accuracy of Autism Diagnostic Observation Schedule-2 in Very Young Children With Modifying the Effect of Global Developmental Delay.

Autism research : official journal of the International Society for Autism Research, 2026

Guideline

practice parameter on the use of psychotropic medication in children and adolescents.

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.